Although the European Union's disinformation policy has significantly developed since 2015, Russia’s war in Ukraine has reminded us all of the urgent need to stay ahead of the curve in order to fortify our resilience against the ever-evolving threat of Foreign Information Manipulation and Interference (FIMI). In the last year, Russia’s strategic use of FIMI in its war of aggression against Ukraine has brought an unprecedented response by those defenders who seek to safeguard universal values, democracy, and freedoms by exposing Russia’s efforts to manipulate global discourses. While governance, law, protocols, data exchange, and forensic practices should converge to address FIMI, they currently remain disparate and unaligned. This fragmented approach creates a significant hurdle in the fight against FIMI, hindering the ability of member states to prosecute, ban, attribute, or sanction FIMI actors or campaigns originating from state and non-state actors. To overcome this hurdle there is a need to better synchronise the interventions and harmonise our approach towards FIMI, as proven in the case of cyberattacks. Our consortium, SAUFEX (Secure Automated Unified Framework for Exchange), comprises of concerned stakeholders who possess significant expertise and hands-on experience with the current systems and structures concerning FIMI and are situated in the EU's Eastern regions, where FIMI incidents are frequently observed. We strongly understand the importance of consolidating and utilising available information to establish a collective comprehension of FIMI. To achieve this, our project proposes the creation of a FIMI data-space, which we will herby refer to as a FIMI knowledge database, as well as the establishment of a Resilience Council to act as an intermediary between state and non-state actors, specifically regarding interventions and FIMI attribution.

Research Infrastructures (RIs) and Technology Infrastructures (TIs) are both essential and complementary elements for functional and efficient R&I ecosystems in Europe. They play a crucial role in strengthening European R&I capacities, from exploratory research to the development, validation and integration of innovative knowledge-based solutions into new products, processes and services. The RITIFI consortium, composed of RI and TI stakeholders from 19 European countries, aims to improve the integration and structure of the European R&I landscape. It will do so by developing a functional framework for the integration of RI and TI services tailored to the needs of end-users, by providing guidelines and methods to improve the visibility and access conditions of RI and TI to end-users, by developing an agile and TI-friendly governance model at European level; provide a comprehensive and multi-level analysis of the RI and TI policy landscape and propose an action plan to ensure alignment and synergies of access policies; develop a process for prioritisation and synergies of investment plans for RI and TI sustainability; raise awareness and stimulate the inclusive engagement of managers, users and policy makers in the development of an integrated RI and TI landscape The project will follow a 4-phase methodology: based on the validation of RI and TI concepts to ensure a common understanding, development of a strategic analysis of the TI landscape and a strategic analysis of the integrated RI and TI landscape in 5 selected areas. Based on the information gathered and extended beyond the selected areas, recommendations to policy makers and the RI-TI community will be drafted. In parallel, the project will engage with the community from the beginning, creating awareness, promoting knowledge sharing, validating results and encouraging adoption. Thus an R&I ecosystem with interconnected and sustainable RI and TI will accelerate the digital and green transition in Europe.

The vision of personalized medicine quickly materializes with increasing computational power employed for delineating the contribution of genetic and lifestyle factors to disease and therapeutic outcomes. However, to help a patient, it is essential to capture a disease status through detailed insight into individuals’ biomedical profile, now enabled thanks to AI-based solutions for big data integration. The access to necessary emerging technologies is currently hampered in many Central-Eastern Europe countries due to an immature culture and insufficient networking of main actors of the R&I sector. The objective of this project is to establish P4Health: a Centre of Excellence for Precise Phenotyping and BioDataBanking, based on the solid foundations of Lukasiewicz-PORT in Wroclaw, Poland. The design of P4Health is rooted in a complementary expertise in preclinical and clinical studies contributed by advanced partners, CERBM (France) and King’s College London (UK). In P4Health, partners will unify existing resources into a coherent workflow combining participatory biobanking, advanced diagnostics, and comprehensive validation of therapeutic strategies in cancer and brain disorders. This synergy will create pillars for new teams to efficiently generate essential data and translate them into economic and societal values. On a scientific level, P4Health will cause structural changes leading to a modernized and more competitive R&I sector in Poland and other Widening countries. On an economic level, P4Health will bring together scientists, clinicians, pharma industry and health case users for creating a forum for knowledge exchange, increased volume of commercialized IP and new business relationships. On a societal level, P4Health will become an expert center for regulatory bodies to support interdisciplinary networks, streamline operations of the health care system, and mobilize the public sector for increased participation in research.

Ł-PORT in Wrocław is a young government institution that conducts cutting-edge research and promotes the commercialisation of scientific discoveries. The aim of the Twinning project is to place the Life Science and Biotechnology Centre (LS&BC) of Ł-PORT in an international network of European biomedical research. This will be achieved by intensifying collaboration with leading neuroscience centres from France, Germany and the Netherlands. The scientific focus of this initiative stems from the shared vision of the consortium partners to develop new solutions for neuropsychiatric diseases. It is estimated that 27% of the EU adult population suffers from at least one mental disorder. These statistics are largely due to inadequate understanding of the biological basis of the disease, leading to suboptimal therapies. Recent studies have discovered numerous genetic risk factors for mental disorders. The next step is to investigate their contribution to disease-related phenotypes using Standardized Approaches to Modelling and Examination of Neuropsychiatric Disorders. The SAME-NeuroID aims to adopt in Ł-PORT the methods developed in the partner laboratories, in order to achieve a consistent experimental workflow to facilitate the discovery and validation of new therapies. Consortium partners will support the LS&BC in boosting the technical skills and management excellence, while educational resources will be utilized to accelerate the formation of the next generation of well-trained scientists. Interdisciplinary activities will be organized to disseminate the unified toolbox and cross-pollinate the existing academic and commercial environments. A comprehensive communication campaign for promoting our results among stakeholders will increase the competitiveness and visibility of Ł-PORT in the international research community. Collectively, the SAME-NeuroID will be a true milestone for positioning LS&BCŁ-PORT as a new hub of excellence for neuroscience in the ERA landscape.